MarketInOut Stock Screener Log In | Sign Up

DiaSorin S.p.A.

MIL • Healthcare • Diagnostics & Research • Quote as of 10/27/2026 17:36
DiaSorin S.p.A. stock price and volume chart

Company Profile

IndustryDiagnostics & Research
SectorHealthcare
ExchangeMIL
Market Capitalization3,954.03 mln
Float19.36 mln
Earnings Date11/05/2026

EPS

2.72
Solid

P / E

29.57
Elevated

Piotroski F-Score

4 / 9
Borderline

Beneish M-Score

-2.75
Likely reliable

1-Year Forecast

76.38
Limited downside

Relative Strength

85 / 100
Strongly outperforming

Business Description

DiaSorin is an Italian company founded in 1968 that develops, manufactures, and sells medical diagnostic testing kits across Europe, North America, and other global markets. Its products help detect and monitor a wide range of conditions, including infectious diseases, hormonal disorders, cancer markers, and liver diseases. The company also offers advanced molecular diagnostic tools capable of identifying specific viruses and fungi from patient samples. DiaSorin operates across both immunodiagnostic and molecular diagnostic fields, serving healthcare providers through several established testing platforms.

Key Fundamentals

EPS2.72
P/E29.57
ROE9.28
RPS22.98
ROIC7.65
ROA4.88
Interest Cover9.72
EBITDA, mln347
EV / EBITDA13.79
EV / EBIT21.74
Revenue, mln1,177
EV / Revenue4.07

Quote Details

Last 80.70
Change -0.2 (-0.25%)
Open 79.88
Volume 112,380
Turnover 9,069,066
Average Volume 155,301

Financial Ratios

Pre-Tax Profit Margin16
Leverage Ratio2.03
Current Ratio1.79
Price / Book2.68
Price / Cash Flow9.35
Price / Free Cash Flow17.99
Debt / Equity0.68
Price / Sales3.52
PEG Ratio1.71

Financial Strength

Altman Z-Score3.44
Piotroski F-Score 4 / 9
Beneish M-Score-2.75
Price to Intrinsic Value1.01
1-Year Target Price76.38
Shiller PE Ratio20.79

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 1.51% 91 / 100   
1 Month 1.79% 75 / 100   
2 Months 20.77% 90 / 100   
6 Months 38.18% 95 / 100   
1 Year 6.45% 59 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog